Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Condition:   Quality of Life Interventions:   Combination Product: concurrent chemoradiotherapy (CCRT);   Drug: Endostar for one cycle;   Drug: Endostar for two cycles Sponsors:   Affiliated Hospital of North Sichuan Medical College;   Jiangsu Simcere Pharmaceutical Co., Ltd. Not yet recruiting

Source: ClinicalTrials.gov - July 17, 2018 Category: Research Source Type: clinical trials